EMGALITY 120 mg/mL

EMGALITY 120 mg/mL is a subcutaneous injection solution containing galcanezumab-gnlm. This medication is designed to help manage specific medical conditions. Learn more about its uses and effects.

EMGALITY 120 mg/mL is primarily used for the prevention of migraine in adults. It is a calcitonin gene-related peptide (CGRP) antagonist, which works by targeting specific pathways involved in migraine. People often ask, 'What is EMGALITY used for?' and the answer is that it is intended for migraine prevention, not for acute treatment.

Common effects of EMGALITY 120 mg/mL may include injection site reactions, such as redness, pain, or swelling. Some users might experience fatigue or constipation. These effects vary among individuals and are not exhaustive.

EMGALITY 120 mg/mL should be stored properly to maintain its efficacy. It is important to follow the handling instructions provided by the manufacturer. Always consult a healthcare provider before starting any new medication.

EMGALITY 120 mg/mL may interact with other medications, including those that affect the liver enzymes CYP450. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions.